ES2094687A1 - Combinacion farmaceutica contra la obesidad o el sobrepeso. - Google Patents

Combinacion farmaceutica contra la obesidad o el sobrepeso.

Info

Publication number
ES2094687A1
ES2094687A1 ES09401714A ES9401714A ES2094687A1 ES 2094687 A1 ES2094687 A1 ES 2094687A1 ES 09401714 A ES09401714 A ES 09401714A ES 9401714 A ES9401714 A ES 9401714A ES 2094687 A1 ES2094687 A1 ES 2094687A1
Authority
ES
Spain
Prior art keywords
brl
inhibitor
excess weight
pharmaceutical combination
obesity
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
ES09401714A
Other languages
English (en)
Other versions
ES2094687B1 (es
Inventor
Lamana Mariano Alemany
Vidal Carlos Monserrat
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
L V A S A Lab SA
Original Assignee
L V A S A Lab SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by L V A S A Lab SA filed Critical L V A S A Lab SA
Priority to ES9401714A priority Critical patent/ES2094687B1/es
Publication of ES2094687A1 publication Critical patent/ES2094687A1/es
Application granted granted Critical
Publication of ES2094687B1 publication Critical patent/ES2094687B1/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Landscapes

  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

NUEVAS COMPOSICIONES O PRODUCTOS FARMACEUTICOS QUE, JUNTO CON EXCIPIENTES ADECUADOS, COMPRENDEN COMO AGENTES ACTIVOS CANTIDADES TERAPEUTICAMENTE EFECTIVAS DE: A) UNA O VARIAS SUBSTANCIAS AGONISTAS BETA-3 ADRENERGICAS, PARTICULARMENTE EL ACTIDO 4-[2-[2-HIDROXI-2- (3-CLOROFENIL) ETILAMINO]PROPIL] FENOXIACETICO (BRL 37344), SU ESTER METILICO (BRL 35135), O EL HIDROBROMURO DE ESTE (BRL 35135A); Y B) UNA O VARIAS SUBSTANCIAS CON EFECTO ANTIGLUCOCORTICOIDE, EN PARTICULAR UNA HORMONA ESTEROIDE, COMO LA DESHIDROEPIANDROSTERONA, Y UN INHIBIDOR DE LA SINTESIS ADRENAL DE GLUCOCORTICOIDES, COMO LA METIRAPONA; EN COMBINACION PARA SU ADMINISTRACION SIMULTANEA, SEPARADA O SUCESIVA. PREFERIBLEMENTE COMPRENDEN ADEMAS: UN INHIBIDOR DE LA ACTIVIDAD FOSFODIESTERASICA, COMO LA CAFEINA; UN INHIBIDOR DE LA SINTESIS DE PROSTAGLANDINAS, COMO LA ASPIRINA; PEQUE¥AS CANTIDADES DE SALES DE CROMO (III), ZINC, MANGANESO Y SELENIO; Y ALDOSTERONA. SON UTILES PARA EL TRATAMIENTO DE LA OBESIDAD O EL SOBREPESO.
ES9401714A 1994-08-02 1994-08-02 Combinacion farmaceutica contra la obesidad o el sobrepeso. Expired - Lifetime ES2094687B1 (es)

Priority Applications (1)

Application Number Priority Date Filing Date Title
ES9401714A ES2094687B1 (es) 1994-08-02 1994-08-02 Combinacion farmaceutica contra la obesidad o el sobrepeso.

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
ES9401714A ES2094687B1 (es) 1994-08-02 1994-08-02 Combinacion farmaceutica contra la obesidad o el sobrepeso.

Publications (2)

Publication Number Publication Date
ES2094687A1 true ES2094687A1 (es) 1997-01-16
ES2094687B1 ES2094687B1 (es) 1997-12-16

Family

ID=8287147

Family Applications (1)

Application Number Title Priority Date Filing Date
ES9401714A Expired - Lifetime ES2094687B1 (es) 1994-08-02 1994-08-02 Combinacion farmaceutica contra la obesidad o el sobrepeso.

Country Status (1)

Country Link
ES (1) ES2094687B1 (es)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2006042733A2 (en) * 2004-10-18 2006-04-27 Oleoyl-Estrone Developments, S.L. Methods of using fatty-acid esters of estrogens and thermogenic compounds for reducing the body weight of a mammal and compositions containing the same
WO2010052563A3 (en) * 2008-11-07 2010-09-16 Aston University Glycoproteins having lipid mobilizing properties and therapeutic uses thereof

Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB833946A (en) * 1957-03-08 1960-05-04 Nordson Pharmaceutical Lab Inc L-amphetamine alginate
US4393049A (en) * 1978-01-23 1983-07-12 Efamol Limited Treatment for obesity
US4920115A (en) * 1988-12-28 1990-04-24 Virginia Commonwealth University Method of lowering LDL cholesterol in blood
WO1991000730A1 (en) * 1989-07-07 1991-01-24 Dak-Laboratoriet A/S A slimming pharmaceutical composition
EP0516350A2 (en) * 1991-05-28 1992-12-02 Zeneca Limited 2-Hydroxy-2-phenylethylamine derivatives as beta-3-adrenoceptor agonists

Patent Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB833946A (en) * 1957-03-08 1960-05-04 Nordson Pharmaceutical Lab Inc L-amphetamine alginate
US4393049A (en) * 1978-01-23 1983-07-12 Efamol Limited Treatment for obesity
US4920115A (en) * 1988-12-28 1990-04-24 Virginia Commonwealth University Method of lowering LDL cholesterol in blood
WO1991000730A1 (en) * 1989-07-07 1991-01-24 Dak-Laboratoriet A/S A slimming pharmaceutical composition
EP0516350A2 (en) * 1991-05-28 1992-12-02 Zeneca Limited 2-Hydroxy-2-phenylethylamine derivatives as beta-3-adrenoceptor agonists

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2006042733A2 (en) * 2004-10-18 2006-04-27 Oleoyl-Estrone Developments, S.L. Methods of using fatty-acid esters of estrogens and thermogenic compounds for reducing the body weight of a mammal and compositions containing the same
WO2006042733A3 (en) * 2004-10-18 2006-12-28 Oleoyl Estrone Developments S Methods of using fatty-acid esters of estrogens and thermogenic compounds for reducing the body weight of a mammal and compositions containing the same
WO2010052563A3 (en) * 2008-11-07 2010-09-16 Aston University Glycoproteins having lipid mobilizing properties and therapeutic uses thereof

Also Published As

Publication number Publication date
ES2094687B1 (es) 1997-12-16

Similar Documents

Publication Publication Date Title
FR2808685B1 (fr) Compositions pharmaceutiques pour administration transdermique d'agents anti-inflammatoires
AU5267900A (en) Carboxylic acid derivatives that inhibit the binding of integrins to their receptors
CA2285389A1 (en) Use of cytoskeletal inhibitors for the prevention of restenosis
KR19980066583A (ko) 스테로이드계 약물의 경피흡수투여용 조성물 및 이를 포함하는 경피흡수투여용 제형
EP1203766B8 (en) Carboxylic acid derivatives that inhibit the binding of integrins to their receptors
MY142403A (en) Oral dosage forms for propiverine or its pharmaceutically acceptable salts with an extended release of the active ingredient
KR20010103559A (ko) 에스트로겐에 민감한 질병을 치료하기 위한 조성물 및 방법
WO2002026217A3 (en) Composition for the transdermal delivery of fentanyl
CA2105180A1 (en) Compositions containing sumatriptan
JPH02500107A (ja) 即効性／強化された鎮痛作用
JP2001508070A (ja) ホルモン剤供給のための経皮吸収治療システム
IL146312A (en) 3-(2-oxo-pyridinyl)-acylamino-propanoic acid derivatives that inhibit the binding of integrins to their receptors and pharmaceutical compositions comprising the same
MY111260A (en) Pharmaceutical composition for the treatment of nicotine dependence
JP2008539236A5 (es)
CA2454339A1 (en) Methods for preventing antipsychotic-induced weight gain
ES2134634T3 (es) Composiciones farmaceuticas y dispositivos para su administracion.
MXPA05001017A (es) Composicion conteniendo un 11¦-halogeno esteroide androgenico y un gestageno asi como un anticonceptivo masculino basado en esta composicion.
ES2065846A1 (es) Formulacion farmaceutica a base de un agente antiinflamatorio esteroidico o no esteroidico y un antibiotico pertenciente al grupo de los inhibidores de la adn girasa para su utilizacion topica oftalmica.
RU2003107072A (ru) Применение гормональной композиции, содержащей сочетание эстрогена и прогестагена
ES2094687A1 (es) Combinacion farmaceutica contra la obesidad o el sobrepeso.
GB2386373A (en) Regulation of glucocorticoid concentration
GEP20043286B (en) Dual Inhibitors of Cholesteryl Ester and Wax Ester Synthesis for Sebaceous Gland Disorders
JP2005533795A5 (es)
CA2248841A1 (en) Sequential oestrogen/progesterone antagonist combination for hormone replacement therapy
CA2163878A1 (en) Agents containing a compound with an anti-androgen effect and a compound with a competitive, progesterone-antagonistic effect

Legal Events

Date Code Title Description
EC2A Search report published

Date of ref document: 19970116

Kind code of ref document: A1

Effective date: 19970116